Independent register of U.S. FDA drug recalls · updated Oct 10, 2026
RxRecalls Get alerts
Class II · Moderate risk Terminated Initiated Mar 25, 2019 (8 years ago)

Bismuth Subsalicylate Oral Suspension 262mg/15mL

Class II — Moderate risk. May cause temporary or reversible harm; serious harm unlikely.

Why it was recalled

Labeling: Incorrect or Missing Lot and/or Exp Date - the label contains an incorrect Exp Date.

Cause type: Labeling / mix-up

Wrong label, wrong strength, mixed-up products, or packaging errors. One of the most dangerous causes - you can end up taking the wrong drug or the wrong dose. All labeling / mix-up recalls.

What was recalled

Bismuth Subsalicylate Oral Suspension 262mg/15mL, unit dose cups, OTC, Rpkg. By.: Lohxa Worcester, MA, NDC 70166-059-01

Affected NDC 70166-0059-01

Compare with the code on your package — it is the most precise check available.

Recalling firm
Lohxa LLC
NDC code
70166-059-01
Origin
MA, United States
Initiated by
Voluntary: Firm initiated
FDA recall number
D-1130-2019 · FDA notice

Check, then ask. Class II means harm is possible but usually temporary or reversible. Find the lot number on your package; if it matches, ask your pharmacist about a replacement. Do not simply stop a prescribed medication on your own - the gap can be riskier than the recall. This recall is now terminated, which means the firm has finished removing the affected product; anything on pharmacy shelves today should be unaffected.

Other recalls by Lohxa LLC

All 2019 recalls
Class I · High risk

Chlorhexidine Gluconate Oral Rinse USP

Microbial contamination of non-sterile products: Repackaged product was recalled by manufacturer because it was contaminated with the bacteria Burkholderia lata.

Terminated Microbial contamination Lohxa LLC NDC 70166-027-15 D-0111-2021
Class II · Moderate risk

Phenobarbital Oral Solution

Labeling: Incorrect or Missing Lot and/or Exp Date - the label contains an incorrect Exp Date.

Terminated Labeling / mix-up Lohxa LLC NDC 70166-536-02 D-1131-2019

Other labeling / mix-up recalls from 2019

All labeling / mix-up recalls
Class II · Moderate risk

Theraflu Cough Relief

Labeling: Label Lacks Warning: Product recalled due to absence of a warning statement on the product label, Ask a doctor before use if you have a sodium-restricted diet.

Terminated Labeling / mix-up GSK Consumer Health, Inc D-0996-2020
Class II · Moderate risk

Testosterone Topical Cream 4%

Labeling: Incorrect or missing lot and/or expiration date. Products were compounded using expired components.

Terminated Labeling / mix-up MPRX, Inc. dba Medical Park Pharmacy D-0820-2020
Class II · Moderate risk

Tadalafil 6 mg Capsule

Labeling: Incorrect or missing lot and/or expiration date. Products were compounded using expired components.

Terminated Labeling / mix-up MPRX, Inc. dba Medical Park Pharmacy D-0819-2020
Class II · Moderate risk

Tadalafil 20 mg Troche

Labeling: Incorrect or missing lot and/or expiration date. Products were compounded using expired components.

Terminated Labeling / mix-up MPRX, Inc. dba Medical Park Pharmacy D-0818-2020